Ascension Sciences specializes in nanoparticle formulation development for cannabinoid therapeutics, providing contract research services that enhance drug delivery efficiency and stability. Their expertise enables research-driven firms to accelerate the development of cannabinoid therapies, reducing time-to-market and improving therapeutic outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Cannabinoid therapeutics face challenges related to poor bioavailability, instability, and inconsistent drug delivery, hindering their efficacy. Traditional formulations often result in variable patient responses and limited therapeutic potential.
Solution
Ascension Sciences offers contract research services specializing in nanoparticle formulation development to enhance cannabinoid therapeutics. Their expertise focuses on improving drug delivery efficiency and stability through advanced nanotechnology. By encapsulating cannabinoids within nanoparticles, Ascension Sciences enables research-driven firms to overcome the limitations of conventional formulations, leading to more predictable and effective therapeutic outcomes. Their services include customized formulation design, optimization, and rigorous testing to ensure the quality and performance of cannabinoid-based products.
Target Audience
Ascension Sciences primarily serves research-driven pharmaceutical and biotechnology companies focused on developing cannabinoid-based therapies.
Features
- Nanoparticle development for enhanced cannabinoid delivery
- Size, quality, and stability testing of nanoparticle formulations
- Encapsulation efficiency and drug loading analysis
- Dissolution and drug release profile characterization
- Comprehensive nanoparticle characterization services
- Cannabinoid concentration analysis via ELISA
- In vitro cell model studies for efficacy evaluation
- Data validation to ensure reliability and accuracy